In this section, you'll find news releases from RSNA 2021 exhibitors. The releases are listed in chronological order and are archived by month and year.
Bracco’s attendance at RSNA follows FDA approval of Gadopiclenol injection, a novel macrocyclic high-relaxivity gadolinium-based contrast agent which will be commercialized as VUEWAYTM (gadopiclenol) injection by Braccoi, ii